| 1 |
34808009 | Prognostic impact of Schlafen 11 in bladder cancer patients treated with platinum-based chemotherapy. | 2022 Feb |
1 |
| 2 |
35021081 | 2-Hydroxyglutarate destabilizes chromatin regulatory landscape and lineage fidelity to promote cellular heterogeneity. | 2022 Jan 11 |
1 |
| 3 |
33382535 | Chromosome 2q gain and epigenetic silencing of GATA3 in microglandular adenosis of the breast. | 2021 May |
1 |
| 4 |
33858483 | Subtype-associated epigenomic landscape and 3D genome structure in bladder cancer. | 2021 Apr 15 |
2 |
| 5 |
33909826 | Combined use of immunohistochemical markers of basal and luminal subtypes in urothelial carcinoma of the bladder: Association with clinicopathological features and outcomes. | 2021 |
1 |
| 6 |
34057115 | Gata-3 and KI-67 expression in correlation with molecular subtypes of breast cancer. | 2021 |
2 |
| 7 |
34108177 | Heterogeneity in NECTIN4 Expression Across Molecular Subtypes of Urothelial Cancer Mediates Sensitivity to Enfortumab Vedotin. | 2021 Sep 15 |
1 |
| 8 |
34117603 | Co-expression of transcription factor AP-2beta (TFAP2B) and GATA3 in human mammary epithelial cells with intense, apicobasal immunoreactivity for CK8/18. | 2021 Dec |
1 |
| 9 |
34358678 | Transcriptome Analysis Identifies GATA3-AS1 as a Long Noncoding RNA Associated with Resistance to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer Patients. | 2021 Oct |
1 |
| 10 |
34517157 | Gene expression analysis of invasive breast carcinoma yields differential patterns in luminal subtypes of breast cancer. | 2021 Dec |
3 |
| 11 |
34561764 | Reduced menin expression leads to decreased ERα expression and is correlated with the occurrence of human luminal B-like and ER-negative breast cancer subtypes. | 2021 Dec |
1 |
| 12 |
34725332 | ARSD, a novel ERα downstream target gene, inhibits proliferation and migration of breast cancer cells via activating Hippo/YAP pathway. | 2021 Nov 2 |
1 |
| 13 |
32429656 | Differences in GATA3 expression among histological/molecular subtypes and grades in infiltrating breast carcinoma (IBC) are important in the diagnosis of metastatic breast carcinoma. | 2020 |
1 |
| 14 |
32546765 | Assessment of Luminal and Basal Phenotypes in Bladder Cancer. | 2020 Jun 16 |
1 |
| 15 |
31376015 | C1orf106, an innate immunity activator, is amplified in breast cancer and is required for basal-like/luminal progenitor fate decision. | 2019 Sep |
1 |